{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:13:43Z","timestamp":1788455623835,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ajog.2020.05.044","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T20:20:00Z","timestamp":1590697200000},"page":"674-708.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["A systematic review of the psychosocial impact of fibroids before and after treatment"],"prefix":"10.1016","volume":"223","author":[{"given":"Virginia Arlene A.","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuchitra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Prenatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime F.","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.05.044_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijgo.2015.04.051","article-title":"Prevalence, morbidity, and current medical management of uterine leiomyomas","volume":"131","author":"Drayer","year":"2015","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.05.044_bib3","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1016\/j.ajog.2007.05.039","article-title":"Inpatient hysterectomy surveillance in the United States, 2000\u20132004","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib4","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/jwh.2005.14.692","article-title":"The economic impact of uterine fibroids in the United States: a summary of published estimates","volume":"14","author":"Mauskopf","year":"2005","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2020.05.044_bib6","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0015-0282(02)04539-9","article-title":"The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life","volume":"79","author":"Pron","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.044_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00006254-200108000-00022","article-title":"Fibroids and infertility: a systematic review of the evidence","volume":"56","author":"Pritts","year":"2001","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2020.05.044_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib10","doi-asserted-by":"crossref","first-page":"96.e102","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.05.044_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Semin Reprod Med"},{"issue":"Suppl_1","key":"10.1016\/j.ajog.2020.05.044_bib12","first-page":"i208","article-title":"220 Women with uterine fibroids have high levels of pain and substantially impaired quality of life (qol)","volume":"26","author":"Barlow","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2020.05.044_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/01674820400024430","article-title":"The illness experiences of women with fibroids: an exploratory qualitative study","volume":"25","author":"Nicholls","year":"2004","journal-title":"J\u00a0Psychosom Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib14","first-page":"290","article-title":"The UFS-QoL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2020.05.044_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/JOM.0b013e31805f6cf2","article-title":"The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids","volume":"49","author":"Lee","year":"2007","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.ajog.2020.05.044_bib17","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1016\/j.fertnstert.2014.07.844","article-title":"Beyond the physical: a qualitative assessment of the emotional burden of symptomatic uterine fibroids on women\u2019s mental health","volume":"102","author":"Ghant","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.044_bib18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1080\/03007995.2017.1372107","article-title":"Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey","volume":"33","author":"Soliman","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2020.05.044_bib19","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.05.044_bib20","author":"Wells"},{"key":"10.1016\/j.ajog.2020.05.044_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00404-013-2775-2","article-title":"Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy","volume":"288","author":"Wang","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.05.044_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/CEOR.S155038","article-title":"Clinical outcomes and health care utilization pre-and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","volume":"10","author":"Rattray","year":"2018","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.fertnstert.2015.11.014","article-title":"PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids","volume":"105","author":"Jacoby","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.044_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijgo.2015.10.008","article-title":"Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy","volume":"133","author":"Kr\u00e4mer","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.05.044_bib25","doi-asserted-by":"crossref","first-page":"345.e1","DOI":"10.1016\/j.ajog.2019.09.052","article-title":"Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF fibroid registry","volume":"222","author":"Laughlin-Tommaso","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiol.2463070260","article-title":"Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy\u2014results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial","volume":"246","author":"Hehenkamp","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.ajog.2020.05.044_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00270-007-9121-7","article-title":"Sexuality and body image after uterine artery embolization and hysterectomy in the treatment of uterine fibroids: a randomized comparison","volume":"30","author":"Hehenkamp","year":"2007","journal-title":"Cardiovasc Interv Rad"},{"key":"10.1016\/j.ajog.2020.05.044_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.ogx.0000503331.67536.b9","article-title":"Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 10 years\u2019 outcomes from the randomized EMMY trial","volume":"71","author":"De Bruijn","year":"2016","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2020.05.044_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jvir.2014.03.009","article-title":"Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study","volume":"25","author":"Shlansky-Goldberg","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2020.05.044_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s42155-018-0044-y","article-title":"Randomised trial of two embolic agents for uterine artery embolisation for fibroids: gelfoam versus embospheres (RAGE trial)","volume":"2","author":"Yadavali","year":"2019","journal-title":"CVIR Endovas"},{"key":"10.1016\/j.ajog.2020.05.044_bib31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib32","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/AOG.0000000000002933","article-title":"Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Carr","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AOG.0000000000003141","article-title":"Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Osuga","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib34","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/AOG.0000000000002942","article-title":"Ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Liu","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003211","article-title":"Health-related quality of life with ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Lukes","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/AOG.0000000000002462","article-title":"Ulipristal acetate for treatment of symptomatic uterine leiomyomas: a randomized controlled trial","volume":"131","author":"Simon","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humrep\/dez007","article-title":"Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials","volume":"34","author":"Stewart","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2020.05.044_bib39","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2018.00030","article-title":"Symptoms and health quality after laparoscopic and robotic myomectomy","volume":"22","author":"Takmaz","year":"2018","journal-title":"JSLS"},{"key":"10.1016\/j.ajog.2020.05.044_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jog.13808","article-title":"Recovery of quality of life after laparoscopic myomectomy","volume":"45","author":"Tsuzuki","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib41","first-page":"2929","article-title":"Analysis of the effect of laparoscopy and hysteroscopy on ovarian function, immune function and quality of sexual life of patients with hysteromyoma at different ages","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajog.2020.05.044_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166659","article-title":"Postoperative quality of life and sexual function in premenopausal women undergoing laparoscopic myomectomy for symptomatic fibroids: a prospective observational cohort study","volume":"11","author":"Radosa","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ajog.2020.05.044_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1447-0756.2009.01149.x","article-title":"The effect of myomectomy on health-related quality of life of women with myoma uteri","volume":"36","author":"Dilek","year":"2010","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/AOG.0b013e3181ed36b3","article-title":"Outcomes from leiomyoma therapies: comparison with normal controls","volume":"116","author":"Spies","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib45","first-page":"1032","article-title":"The effect of myoma uteri and myomectomy on sexual function","volume":"6","author":"Ertunc","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ajog.2020.05.044_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2017.12.025","article-title":"Outcome of magnetic resonance-guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids","volume":"221","author":"Mashiach","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.05.044_bib47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/uog.7435","article-title":"Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas","volume":"34","author":"Taran","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/gyn.2018.0051","article-title":"Long-term clinical outcomes of transcervical radiofrequency ablation of uterine fibroids: the VITALITY study","volume":"35","author":"Garza-Leal","year":"2019","journal-title":"J\u00a0Gynecol Surg"},{"key":"10.1016\/j.ajog.2020.05.044_bib49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/02656736.2017.1421323","article-title":"A\u00a0retrospective study of ultrasound-guided high intensity focused ultrasound ablation for multiple uterine fibroids in South Africa","volume":"34","author":"He","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ajog.2020.05.044_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/IJWH.S201912","article-title":"12-month outcomes of the US patient cohort in the Sonata pivotal IDE trial of transcervical ablation of uterine fibroids","volume":"11","author":"Hudgens","year":"2019","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2020.05.044_bib51","first-page":"1","article-title":"Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms","author":"Ierardi","year":"2019","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"10.1016\/j.ajog.2020.05.044_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/AOG.0000000000003032","article-title":"Ultrasound-guided transcervical ablation of uterine leiomyomas","volume":"133","author":"Chudnoff","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","article-title":"The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids","volume":"13","author":"Br\u00f6lmann","year":"2016","journal-title":"Gynecol Surg"},{"issue":"6","key":"10.1016\/j.ajog.2020.05.044_bib54","article-title":"Three years\u2019 outcome from the halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas","volume":"21","author":"Berman","year":"2014","journal-title":"J\u00a0Minim Invas Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13104-017-2558-0","article-title":"One year symptom severity and health-related quality of life changes among black African patients undergoing uterine fibroid embolisation","volume":"10","author":"Mariara","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ajog.2020.05.044_bib56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.fertnstert.2008.06.007","article-title":"Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids","volume":"92","author":"Voogt","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.044_bib57","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.ajog.2004.02.043","article-title":"Patient satisfaction and disease specific quality of life after uterine artery embolization","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib58","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00192-012-2013-7","article-title":"The effect of uterine fibroid embolization on lower urinary tract symptoms","volume":"24","author":"Shveiky","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ajog.2020.05.044_bib59","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1051-0443(99)70235-6","article-title":"Uterine fibroid embolization: measurement of health-related quality of life before and after therapy","volume":"10","author":"Spies","year":"1999","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2020.05.044_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajog.2004.03.037","article-title":"Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study","volume":"191","author":"Spies","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejogrb.2010.10.022","article-title":"Prospective comparison of laparoscopic uterine\u00a0artery occlusion plus myomectomy with\u00a0classic intrafascial supracervical hysterectomy for symptomatic fibroid treatment: differences in post-operative quality-of-life measures","volume":"155","author":"Liu","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.05.044_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40349-016-0072-9","article-title":"The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in china","volume":"4","author":"Chen","year":"2016","journal-title":"J\u00a0Ther Ultrasound"},{"key":"10.1016\/j.ajog.2020.05.044_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/2331205X.2017.1360543","article-title":"Assessment of uterine fibroid infarction after embolization with tris-acryl gelatin microspheres","volume":"4","author":"Duvnjak","year":"2017","journal-title":"Cogent Med"},{"key":"10.1016\/j.ajog.2020.05.044_bib64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s42155-019-0080-2","article-title":"Impact of uterine contractility on quality of life of women undergoing uterine fibroid embolization","volume":"2","author":"Fornazari","year":"2019","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.ajog.2020.05.044_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1477-7525-11-139","article-title":"Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years\u2019 outcome from the halt trial","volume":"11","author":"Guido","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ajog.2020.05.044_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40349-017-0100-4","article-title":"Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects","volume":"5","author":"Keserci","year":"2017","journal-title":"J\u00a0Ther Ultrasound"},{"key":"10.1016\/j.ajog.2020.05.044_bib67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/gyn.2009.0101","article-title":"Radiofrequency thermal ablation of submucosal leiomyoma: a preliminary report on health, symptom, and quality of life outcomes","volume":"26","author":"Lee","year":"2010","journal-title":"J\u00a0Gynecol Surg"},{"key":"10.1016\/j.ajog.2020.05.044_bib68","first-page":"263","article-title":"Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation: the initial experience in Taiwan","volume":"34","author":"Lin","year":"2009","journal-title":"Chin. J Radiol"},{"key":"10.1016\/j.ajog.2020.05.044_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02656736.2018.1479778","article-title":"Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study","volume":"35","author":"Turtulici","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ajog.2020.05.044_bib70","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1051-0443(07)61591-7","article-title":"Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata","volume":"12","author":"Spies","year":"2001","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2020.05.044_bib71","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.AOG.0000188386.53878.49","article-title":"The FIBROID registry: symptom and quality-of-life status 1 year after therapy","volume":"106","author":"Spies","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib72","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/09513590.2019.1576618","article-title":"Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health","volume":"35","author":"Neri","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2020.05.044_bib73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2018.06.027","article-title":"Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids","volume":"228","author":"Tuschy","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.05.044_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2009.11.019","article-title":"Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone","volume":"109","author":"Feng","year":"2010","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.05.044_bib75","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2016.06.012","article-title":"Role of ethnicity in treating uterine fibroids with ulipristal acetate","volume":"106","author":"Murji","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.044_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:QURE.0000018472.46236.05","article-title":"Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQoLA) Project","volume":"13","author":"Alonso","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4048\/jbc.2012.15.4.449","article-title":"Health-related quality of life in breast cancer patients with lymphedema who survived more than one year after surgery","volume":"15","author":"Lee","year":"2012","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.ajog.2020.05.044_bib78","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/PPA.S143944","article-title":"Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China","volume":"11","author":"Xu","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ajog.2020.05.044_bib79","doi-asserted-by":"crossref","first-page":"e23556","DOI":"10.5812\/ircmj.23556","article-title":"Comparison of SF-6D and EQ-5D scores in patients with breast cancer","volume":"18","author":"Yousefi","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.ajog.2020.05.044_bib80","doi-asserted-by":"crossref","first-page":"174.e1","DOI":"10.1016\/j.ajog.2018.10.032","article-title":"FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery","volume":"220","author":"Laughlin-Tommaso","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib81","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0","article-title":"Confirmation of the dimensional structure of the scl-90: a study in construct validation","volume":"33","author":"Derogatis","year":"1977","journal-title":"J\u00a0Clin Psychol"},{"key":"10.1016\/j.ajog.2020.05.044_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0959-8049(00)00353-1","article-title":"A\u00a0body image scale for use with cancer patients","volume":"37","author":"Hopwood","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2020.05.044_bib83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"10.1016\/j.ajog.2020.05.044_bib84","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF01541816","article-title":"Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women","volume":"23","author":"Taylor","year":"1994","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.ajog.2020.05.044_bib85","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00192-003-1063-2","article-title":"A\u00a0short form of the Pelvic Organ prolapse\/Urinary Incontinence Sexual Questionnaire (PISQ-12)","volume":"14","author":"Rogers","year":"2003","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ajog.2020.05.044_bib86","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1008974420049","article-title":"A\u00a0health related quality of life measure for use in patients with urge urinary incontinence: a validation study","volume":"8","author":"Lubeck","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib87","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/791200711","article-title":"Does mode of hysterectomy influence micturition and defecation?","volume":"80","author":"Roovers","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2020.05.044_bib88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-013-0442-5","article-title":"Validation of the SF-36 in patients with endometriosis","volume":"23","author":"Stull","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib89","first-page":"22","article-title":"Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in adults with non-cancer pain","volume":"5","author":"Hayes","year":"2017","journal-title":"Healthcare Version 2"},{"key":"10.1016\/j.ajog.2020.05.044_bib90","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/humrep\/dex057","article-title":"Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the Endometriosis Health Profile-5 (EHP-5) and the EuroQol-5D (EQ-5D)","volume":"32","author":"Aubry","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2020.05.044_bib91","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.bjc.6600895","article-title":"Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy","volume":"88","author":"Sung","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2020.05.044_bib92","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1479-828X.2009.01131.x","article-title":"Validation of the WHOQOL-bref among women following childbirth","volume":"50","author":"Webster","year":"2010","journal-title":"Aus N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.05.044_bib93","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0","article-title":"Confirmation of the dimensional structure of the scl-90: a study in construct validation","volume":"33","author":"Derogatis","year":"1977","journal-title":"J\u00a0Clin Psychol"},{"key":"10.1016\/j.ajog.2020.05.044_bib94","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"10.1016\/j.ajog.2020.05.044_bib95","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF01541816","article-title":"Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women","volume":"23","author":"Taylor","year":"1994","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.ajog.2020.05.044_bib96","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00192-003-1063-2","article-title":"A\u00a0short form of the Pelvic Organ prolapse\/Urinary Incontinence Sexual Questionnaire (PISQ-12)","volume":"14","author":"Rogers","year":"2003","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ajog.2020.05.044_bib97","series-title":"4de versie: Validatiestudies. [Questionnaire for screening Sexual Dysfunctions (QSD). 4th version: validation studies.]","author":"Vroege","year":"1996"},{"key":"10.1016\/j.ajog.2020.05.044_bib98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00435972","article-title":"The Sexual Activity Questionnaire: A measure of women\u2019s sexual functioning","volume":"5","author":"Thirlaway","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib99","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1008974420049","article-title":"A\u00a0health related quality of life measure for use in patients with urge urinary incontinence: a validation study","volume":"8","author":"Lubeck","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ajog.2020.05.044_bib100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/791200711","article-title":"Does mode of hysterectomy influence micturition and defecation?","volume":"80","author":"Roovers","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2020.05.044_bib101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0959-8049(00)00353-1","article-title":"A\u00a0body image scale for use with cancer patients","volume":"37","author":"Hopwood","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2020.05.044_bib102","first-page":"290","article-title":"The UFS-QoL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820306001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820306001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:54:31Z","timestamp":1774461271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820306001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0002937820306001"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.05.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the psychosocial impact of fibroids before and after treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}